|
2021
|
Invention
|
Anti-par-2 antibodies and methods of use thereof. The present disclosure provides antibodies and ... |
|
2020
|
Invention
|
Liquid formulations of bendamustine.
Stable liquid formulations of bendamustine, and pharmaceuti... |
|
2019
|
Invention
|
Novel solid forms of bendamustine hydrochloride.
Novel solid forms of bendamustine hydrochloride... |
|
|
Invention
|
Anti-cxcr2 antibodies and uses thereof. Disclosed herein are human antibody molecules that immuno... |
|
|
Invention
|
Prodrugs of chlorokynurenines.
The present disclosure relates to prodrugs of 7-chlorokynurenic a... |
|
2018
|
Invention
|
Antibody peptide mapping and characterization using an erlic-ms/ms method. Disclosed herein are m... |
|
|
Invention
|
Fused bicyclic 2,4-diaminopyrimidine derivative as a dual alk and fak inhibitor. The present inve... |
|
|
Invention
|
Cation exchange chromatography wash buffer. A wash buffer comprising a surfactant for use in affi... |
|
|
Invention
|
Bendamustine pharmaceutical compositions.
The present invention provides pharmaceutical formul... |
|
2017
|
Invention
|
Antibodies that specifically bind to human il-15 and uses thereof. Recombinant antibodies that sp... |
|
|
Invention
|
Anti-il-5 antibodies. Disclosed herein are fully human antibody molecules that immunospecifically... |
|
|
Invention
|
Spiropiperidine derivatives. Described herein are spiropiperidine compounds according to Formula ... |
|
|
Invention
|
Antibody variants transmigrating the blood-brain barrier and uses thereof. The present invention ... |
|
|
Invention
|
Use of reslizumab to treat moderate to severe eosinophilic asthma. Disclosed herein are methods o... |
|
|
Invention
|
Inhalation systems, devices and methods.
Digital systems, devices and methods for managing a dru... |
|
|
Invention
|
Affinity chromatography wash buffer. A wash buffer comprising greater than 0 mM and less than abo... |
|
|
Invention
|
Pharmaceutical prodrugs and methods of their preparation and use. The disclosure provides compoun... |
|
2016
|
Invention
|
Substituted aromatic sulfur compounds and methods of their use.
Compounds of formula II are desc... |
|
|
Invention
|
Macrocyclic compounds as alk, fak and jak2 inhibitors.
The present invention provides compounds ... |
|
|
Invention
|
Antibodies that specifically bind to tl1a. Recombinantly expressed variant antibodies that have e... |
|
|
Invention
|
Prodrugs of chlorokynurenines. The present disclosure relates to prodrugs of 7-chlorokynurenic ac... |
|
|
Invention
|
Pyrrolotriazines as alk inhibitors.
This application provides compounds of the general formula (... |
|
|
Invention
|
Substituted 4-benzyl and 4-benzoyl piperidine derivatives. Described herein are 1,4-substituted p... |
|
|
Invention
|
1, 4-substituted piperidine derivatives. Described herein are 1,4-substituted piperidine compound... |
|
2015
|
Invention
|
Methods for preparing fused bicyclic 2, 4-diaminopyrimidine derivatives. The present disclosure i... |
|
|
Invention
|
Crystalline forms of parp inhibitors. The present disclosure relates to crystalline forms of 4,5,... |
|
|
Invention
|
Pyrrolotriazines as alk inhibitors. This application provides compounds of the general formula (I... |
|
|
Invention
|
Nanoparticulate and macroparticulate formulations. The present invention is directed to doxorubic... |
|
|
Invention
|
Child resistant cover for oral dosage forms.
A child resistant safety device for an oral dosage ... |
|
|
Invention
|
Tricyclic derivatives and their pharmaceutical use and compositions.
This application relates to... |
|
2014
|
Invention
|
Treatment of multiple sclerosis with a 1,2,4-triazolo [1,5a] pyridine derivative.
The present di... |
|
|
Invention
|
Treatment of multiple sclerosis with a 1,2,4-triazolo [1,5a] pyridine derivative. The present dis... |
